Personality disorders and cause-specific mortality: a nationwide study of 2 million adolescents.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 15 10 2020
medline: 16 7 2022
entrez: 14 10 2020
Statut: ppublish

Résumé

Personality disorders are prevalent in 6-10% of the population, but their risk for cause-specific mortality is unclear. The aim of the study was to assess the association between personality disorders diagnosed in late adolescence and all-cause as well as cause-specific (cardiovascular-related, external-related) mortality. We performed a longitudinal study on a historical prospective cohort based on nationwide screening prior to recruitment to the Israeli army. The study participants were 16-19-year-old persons who attended the army screening (medical and cognitive, including screening for psychiatric disorders) between 1967 and 2006. Participants were followed from 1967 till 2011. The study included 2 051 606 subjects, of whom 1 229 252 (59.9%) were men and 822 354 (40.1%) were women, mean age 17.36 years. There were 55 508 (4.5%) men and 8237 (1.0%) women diagnosed with personality disorders. The adjusted hazard ratio (HRs) for coronary, stroke, cardiovascular, external-related causes and all-cause mortality among men with personality disorders were 1.34 (1.03-1.74), 1.82 (1.20-2.76), 1.45 (1.23-1.71), 1.41 (1.30-1.53) and 1.44 (1.36-1.51), respectively. The absolute rate difference for all-cause mortality was 56.07 and 13.19 per 10 Personality disorder in late adolescence is associated with increased risk of cardiovascular, external- and all-cause mortality. Increased cardiovascular mortality is evident before the age of 40 years and may point to the importance of lifestyle education already in youth.

Sections du résumé

BACKGROUND
Personality disorders are prevalent in 6-10% of the population, but their risk for cause-specific mortality is unclear. The aim of the study was to assess the association between personality disorders diagnosed in late adolescence and all-cause as well as cause-specific (cardiovascular-related, external-related) mortality.
METHODS
We performed a longitudinal study on a historical prospective cohort based on nationwide screening prior to recruitment to the Israeli army. The study participants were 16-19-year-old persons who attended the army screening (medical and cognitive, including screening for psychiatric disorders) between 1967 and 2006. Participants were followed from 1967 till 2011.
RESULTS
The study included 2 051 606 subjects, of whom 1 229 252 (59.9%) were men and 822 354 (40.1%) were women, mean age 17.36 years. There were 55 508 (4.5%) men and 8237 (1.0%) women diagnosed with personality disorders. The adjusted hazard ratio (HRs) for coronary, stroke, cardiovascular, external-related causes and all-cause mortality among men with personality disorders were 1.34 (1.03-1.74), 1.82 (1.20-2.76), 1.45 (1.23-1.71), 1.41 (1.30-1.53) and 1.44 (1.36-1.51), respectively. The absolute rate difference for all-cause mortality was 56.07 and 13.19 per 10
CONCLUSIONS
Personality disorder in late adolescence is associated with increased risk of cardiovascular, external- and all-cause mortality. Increased cardiovascular mortality is evident before the age of 40 years and may point to the importance of lifestyle education already in youth.

Identifiants

pubmed: 33050953
doi: 10.1017/S0033291720003530
pii: S0033291720003530
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1746-1754

Auteurs

Shmuel Tiosano (S)

Department of Medicine 'B' and Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Lucian Laur (L)

Surgeon General Headquarters, Israel Defense Forces, Ramat Gan, Israel and Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Amir Tirosh (A)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Israel.

Ariel Furer (A)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Surgeon General Headquarters, Israel Defense Forces, Ramat Gan, Israel and Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Arnon Afek (A)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Central Management, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Noam Fink (N)

Surgeon General Headquarters, Israel Defense Forces, Ramat Gan, Israel and Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Estela Derazne (E)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Surgeon General Headquarters, Israel Defense Forces, Ramat Gan, Israel and Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Dorit Tzur (D)

Surgeon General Headquarters, Israel Defense Forces, Ramat Gan, Israel and Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Eyal Fruchter (E)

Department of psychiatry, Rambam Medical Center, Technion-Israel Institute of Technology, Haifa, Israel.

Ariel Ben-Yehuda (A)

Surgeon General Headquarters, Israel Defense Forces, Ramat Gan, Israel and Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Tarif Bader (T)

Surgeon General Headquarters, Israel Defense Forces, Ramat Gan, Israel and Department of Military Medicine, Hebrew University, Jerusalem, Israel.

Howard Amital (H)

Department of Medicine 'B' and Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Moyses Szklo (M)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Mark Weiser (M)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Department of psychiatry, Sheba Medical Center, Tel-Hashomer, Israel.

Gilad Twig (G)

Surgeon General Headquarters, Israel Defense Forces, Ramat Gan, Israel and Department of Military Medicine, Hebrew University, Jerusalem, Israel.
Institute of Endocrinology, Sheba Medical Center, Tel Hashomer, Israel.
Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH